Jacob Rubens
Founder of Sana Biotechnology
Jacob Rubens
Founder of Sana Biotechnology
Cambridge, Massachusetts
Overview
Work Experience
Chief Executive Officer
2024 - Current
President
2021 - 2024
Origination Partner
2023
Senior Principal
2021 - 2023
Principal
2019 - 2021
Senior Associate
2018 - 2019
Associate
2015 - 2018
VentureLabs Fellow
2015 - 2015
Co-Founder
2018
Chief Innovation Officer
2018
Chief Scientific Officer
2018 - 2021
Co-Founder
2019
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells and gene therapies as medicines. This new class of medicines is based on recent scientific advances that make it possible to treat a broad array of diseases. We are a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that will change how we approach treating disease.
Co-Founder and Head of Innovation
2016 - 2018
Cobalt Biomedicine is developing a new class of therapeutics based on the ability to deliver into cells essentially any biological payload, ranging from defined molecular polymers to cellular organelles, with unprecedented cell specificity. This approach enables direct and highly targeted intervention inside the cell opening up vast opportunities across diverse therapeutic areas, with the potential to transiently or permanently correct for defects at the root of diseases. Cobalt Biomedicine was founded by Flagship Pioneering.
Scientific Strategy and Operations
2016 - 2016
Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maintain health. Since its founding in 2015 by Flagship Pioneering, Kaleido has advanced candidate products into clinical studies across programs in rare genetic diseases, oncology and infectious disease, and has generated more than 3,000 days of human clinical data. The Company is also creating consumer products that optimize the microbiome's natural roles in promoting health.
PHD Student
2010 - 2015
Synthetic Biology Center with Tim Lu
Instructor
2012 - 2014
MIT's Office of Engineering Outreach Programs (OEOP) SEED Academy
Co Founder
2014 - 2015
Enterosense worked on a medical device for measuring biomarkers in the gut
Project Leader and Team Founder
2009 - 2010
Undergraduate Research Assistant
2008 - 2010